Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency
Status:
Terminated
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
The general aim of this study in adult patients with Autosomal Dominant Polycystic Kidney
Disease (ADPKD) and severe renal insufficiency is to assess the safety and the efficacy of
sirolimus (SRL) in slowing renal function decline as compared to conventional therapy.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Mario Negri Institute for Pharmacological Research